Ostrowski Erik's Form 4 filing
Akebia Therapeutics, Inc. (AKBA) · filed Jul 1, 2026
- Accession no.
- 0001762507-26-000004
- Filed
- Jul 1, 2026, 4:34 PM ET
- Trade date
- Jun 29, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $62.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ostrowski ErikCIK 0001762507 | Officer (SVP, CFO, CBO & Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | SSaleDisposed | −56,019 | $1.11 | −$62,181.09 | 616,616 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.